<DOC>
	<DOCNO>NCT01294176</DOCNO>
	<brief_summary>The purpose study determine oral lipoic acid safely help relieve permanent optic nerve injury patient diagnose acute optic neuritis . It also explore body absorbs break study drug , effect immune system .</brief_summary>
	<brief_title>Lipoic Acid Treatment Acute Optic Neuritis</brief_title>
	<detailed_description>Oral lipoic acid antioxidant help proteins work body . It available oral intravenous formulation use past treat nerve damage like see diabetes metabolic disorder . It available dietary supplement United States . Patients diagnosis acute optic neuritis enrol study undergo medical nervous system examination , blood draw . The study doctor take medical history perform physical examination . Research assistants MS Center , train blood draw , perform blood draw . Patients also undergo Optical coherence tomography ( OCT ) examination Casey Eye Institute , receive two MRIs Oregon Health Science University ( OHSU ) . Because placebo-controlled trial , subject 50:50 chance receive either placebo ( inactive ) study drug . If enrol study , patient take two gel capsule study drug placebo time every day six week .</detailed_description>
	<mesh_term>Optic Neuritis</mesh_term>
	<mesh_term>Neuritis</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Diagnosis acute , unilateral AON visual symptom ( vision loss ) 14 day less 18 65 year age , inclusive AON first event ( possibly idiopathic ) relationship clinically isolate syndrome MS accord McDonald criterion No previous history optic neuritis ophthalmoscopic sign optic atrophy affect eye Subject available treatment initiation within 14 day onset AON symptoms Other cause visual loss affect eye ( e.g . amblyopia glaucoma OCT nonevaluable screen visit due edema . AON symptom improve administration study medication . Subject fever active infection time enrollment . Subject pregnant breastfeeding . Subject diabetes mellitus . Subject another significant health problem ( e.g . active coronary heart disease , liver disease , significant pulmonary disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Optic Neuritis</keyword>
	<keyword>Lipoic Acid</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Antioxidant</keyword>
	<keyword>OCT</keyword>
	<keyword>Acute</keyword>
</DOC>